Gemcitabine and doxorubicin in immunostimulatory monophosphoryl lipid A liposomes for treating breast cancer

Cancer therapy is increasingly shifting toward targeting the tumor immune microenvironment and influencing populations of tumor infiltrating lymphocytes. Breast cancer presents a unique challenge as tumors of the triple‐negative breast cancer subtype employ a multitude of immunosilencing mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Debra, Zhao, Zongmin, Kim, Jayoung, Razmi, Amaya, Wang, Lily Li‐Wen, Kapate, Neha, Gao, Yongsheng, Peng, Kevin, Ukidve, Anvay, Mitragotri, Samir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2020
Materias:
Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823124/
https://www.ncbi.nlm.nih.gov/pubmed/33532588
http://dx.doi.org/10.1002/btm2.10188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7823124/
https://www.ncbi.nlm.nih.gov/pubmed/33532588
http://dx.doi.org/10.1002/btm2.10188

Ejemplares similares